Although it is still too early to determine what the outcome of this outburst could be and how far it could spread, there is one aspect many experts agree with: the world seems to be more prepared than ever, this outbreak
"The political level at the national, regional and global levels is determined to support this," Schuchat said WHO's response this year.
 In addition, "Democratic Republic of Congo has had Ebola epidemics before." This is the ninth. This is serious, since it is not only in a rural area, but has reached an urban area, but there is more familiarity with the disease and syndrome than there was in West Africa, "Schuchat said. Even at the outbreak in 2014-2016, research was just beginning to test Ebola vaccines and drug candidates in humans.
"We now have very good experience with one of the vaccines tested in the ring vaccine trial in Guinea and have also been tested in large studies in Sierra Leone and Liberia and appear to be very effective and very safe," she said. "We do not have any approved vaccines or medicines yet, but we have promising vaccine and drug candidates."
"We now have tools"
In the outbreak of 2014/16, researchers were at a very early stage in the development of potential vaccines, and testing started only in the last days of the outbreak.
"Ri In a vaccine you identify someone who has Ebola and you identify the contacts of that person and the contacts of the contacts, and you vaccinate them with the rVSV vaccine." This is the main difference between the beginning of the outbreak in West Africa and what we see now, "said Fauci.
"We did not have any tools back then, and when we got the vaccine ready for testing, most of them were burned out," he said. "We now have tools."
The doses sent by Merck to WHO to help the current outbreak, said spokeswoman Pam Eisele Tuesday, that the company plans plans for approval of the vaccine next year.
The experimental drugs that give hope
Experimental Ebola drugs – including ZMapp, favipiravir and GS-5734 – are available to the Ministry of Health of the Congo to gain access, if necessary, to treat patients in the current outbreak.
"The Minister of Health The Democratic Republic of the Congo has requested access to this antibody, "Fauci said." We are ready to provide mAb114 for them, and we are working with the health authorities in the Democratic Republic of the Congo and in coordination with the WHO to determine whether this is feasible. "
Bamford pointed out that these experimental drugs are giving hope not only to control the current outbreak, but to future outbreaks.
"We should strive to get antiviral drugs for Ebola, not just to save lives, but also to help communities who consider Ebola incurable to help their infection to authorities," he said. "Antiviral drugs give hope to the infected, and maybe ZMapp, favipiravir and GS-5734 are these drugs, but we do not know yet."
"The only clear difference I see between this outbreak and the 2014-2016 outbreak is the more robust response to this outbreak, which lacked the early introduction of vaccines, therapeutics, and external health advisors in early 2014," said Ribner. "We are also a little luckier, because the Congo has lived with Ebola."
"Every new outbreak teaches us a new lesson"
"So they are experienced in dealing with an Ebola outbreak," said Fauci.
Compared to the 2014/16 outbreak, "that's a huge difference, because in West Africa – in Sierra Leone, Liberia and Guinea – it was the first time they had experienced Ebola.
"In the last outburst you probably felt in retrospect The local, national, international response to The outbreak was not as fast and as widespread as needed. We have been working to prevent the outbreak from becoming so big, "said Kline, a member of the Society of Infectious Diseases at the US Department of Health  "I think people have learned from this experience that in order to control an outbreak, you have to work really fast, not just about Ebola Identify and isolate treatment centers, but also to do publicity work to identify contacts, "she said.
In response to the Congo outbreak, the US has deployed a number of Ebola experts from the CDC to help with control efforts such as screening and tracing Ebola cases, Schuchat said ,  She added that the CDC has an office in Congo where workers have postponed their tasks to support the outbreak. Other organizations are also leaders in clinical care and outbreak control, including Medecins Sans Frontières (MSF), UNICEF and USAID.
All in all, "We know that we have the tools to fight outbreaks now and in the future, we know we can not be complacent," Bamford said.
"We still do not know everything there is to know about the Ebola virus and every new outbreak teaches us a new lesson, such as the virus's ability to slumber in some rare patients, where it flares up years later could. "he said. "With Ebola we have to expect the unexpected."
CNN's Natalie Gallon, Euan McKirdy, Al Goodman and Susan Scutti contributed to this report.